Stock analysis searches answered, part 24 of 43

Plumas bancorp bullish and bearish analyst opinions

For “Plumas bancorp bullish and bearish analyst opinions”, the matching SEC registrant is PLUMAS BANCORP, which trades as PLBC and files under Central Index Key 1168455. EDGAR puts it in the “Short-Term Business Credit Institutions” industry code with CA as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-22, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-19 by PLUMAS BANCORP (CIK 1168455) — source document:

References in this report to the “Company,” “we,” “us” and “our” refer to Plumas Bancorp and its consolidated subsidiary, unless the context indicates otherwise. References to the “Bank” refer to Company’s wholly-owned subsidiary, Plumas Bank. References to “Management” refer to the members of the Company’s management and references to the “Board of Directors” or the “Board” refer to the Company’s Board of Directors. General The Company . Plumas Bancorp is a bank holding company headquartered in Reno, Nevada. Substantially all of the Company's operations are conducted through its subsidiary, Plumas Bank, which is also the principal source of the Company’s revenue. At December 31, 2025, the Company had consolidated assets of $2.2 billion, deposits of $1.8 billion, other liabilities of $168 million and shareholders’ equity of $261 million.

Financial trend for PLUMAS BANCORP from annual reports, periods 2023-12-31 to 2025-12-31: net income (loss) went from $29.78 million (2023-12-31) to $29.62 million (2025-12-31), a change of -0.5%; total assets went from $1.61 billion (2023-12-31) to $2.24 billion (2025-12-31), a change of +39.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1168455, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerIncludingAssessedTax; 4 periods shown, dashes mark figures PLUMAS BANCORP did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on PLUMAS BANCORP (CIK 1168455) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-10-21, and the most recent 10-K annual report was filed 2026-03-19. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 284 8-K or 6-K reports in PLUMAS BANCORP’s recent EDGAR index, the 4 listed here run from 2026-10-21 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1168455 is on the EDGAR company page; the latest 10-K there is dated 2026-03-19 and the oldest filing in the recent index dates from 2005-05-12. Insider trades for PLUMAS BANCORP appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Pt atlas nexus group tbk bullish and bearish analyst opinions

“PT … Tbk” is the Indonesian form for a public limited company (Perseroan Terbatas Terbuka), the label used by companies listed on IDX. The name “Pt atlas nexus group tbk” therefore points to a company organised in Indonesia, and its official disclosures are on the Indonesia Stock Exchange (IDX) company-announcement system, supervised by OJK (www.idx.co.id), not on EDGAR.

No SEC filer could be matched to “Pt atlas nexus group tbk bullish and bearish analyst opinions” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Pt atlas nexus group tbk”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “atlas” (search terms considered: atlas, nexus).

Even the shorter phrase “Pt atlas nexus” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (atlas, nexus) point to a business outside the SEC system or one known by another legal name.

The wording suggests a business based in Indonesia. Companies there file with Indonesia Stock Exchange (IDX) and the Financial Services Authority (OJK) rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “atlas” is therefore the Indonesia regulator or exchange site, where annual reports and stock-exchange announcements are published.

EDGAR’s company index has 181+ entities whose registered name contains the word “atlas”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “atlas” 464, “nexus” 239. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “atlas” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Pt bank pan indonesia tbk bullish and bearish analyst opinions

The legal-form ending in “Pt bank pan indonesia tbk” is the clue: “PT … Tbk” is the Indonesian form for a public limited company (Perseroan Terbatas Terbuka), the label used by companies listed on IDX. A company of that kind reports in Indonesia, so the place to read its annual report and announcements is the Indonesia Stock Exchange (IDX) company-announcement system, supervised by OJK — www.idx.co.id.

No SEC filer could be matched to “Pt bank pan indonesia tbk bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Pt bank pan indonesia tbk” appears in 1037+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “pan” (search terms considered: bank, pan, indonesia).

A broader EDGAR full-text search for the shorter phrase “Pt bank pan” finds 1099+ filing documents; among the top 100, the filers mentioning it most are DIMENSIONAL EMERGING MARKETS VALUE FUND INC (CIK 0000896163) (18); TIFF INVESTMENT PROGRAM INC (CIK 0000916622) (13); INDONESIA FUND INC (CIK 0000859120) (10). Those are documents that name the term, not proof that any of these filers is the business in the search.

The wording suggests a business based in Indonesia. Companies there file with Indonesia Stock Exchange (IDX) and the Financial Services Authority (OJK) rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “pan” is therefore the Indonesia regulator or exchange site, where annual reports and stock-exchange announcements are published.

In the 100 most relevant full-text hits returned for “Pt bank pan indonesia tbk”, filings range from 2001-01-03 to 2023-08-28. The filers whose documents mention it most often are DIMENSIONAL EMERGING MARKETS VALUE FUND INC (CIK 0000896163) (20 hits); INDONESIA FUND INC (CIK 0000859120) (10 hits); ASIA PACIFIC FUND INC (CIK 0000795618) (10 hits); TIFF INVESTMENT PROGRAM INC (CIK 0000916622) (9 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 186+ entities whose registered name contains the word “pan”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “bank” 459, “pan” 257, “indonesia” 36. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “pan” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Pt electronic city indonesia tbk bullish and bearish analyst opinions

Read from its name, “Pt electronic city indonesia tbk” is a Indonesia entity — “PT … Tbk” is the Indonesian form for a public limited company (Perseroan Terbatas Terbuka), the label used by companies listed on IDX. Its accounts and exchange notices are published through the Indonesia Stock Exchange (IDX) company-announcement system, supervised by OJK (www.idx.co.id); the SEC only receives filings from such a company if it sells registered securities in the U.S.

No SEC filer could be matched to “Pt electronic city indonesia tbk bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Pt electronic city indonesia tbk” appears in 9 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “electronic” (search terms considered: electronic, city, indonesia).

A broader EDGAR full-text search for the shorter phrase “Pt electronic city” finds 19 filing documents; among the top 19, the filers mentioning it most are MATTHEWS INTERNATIONAL FUNDS (CIK 0000923184) (12); iSHARES TRUST (CIK 0001100663) (4); MORGAN STANLEY ASIA-PACIFIC FUND, INC. (CIK 0000919808) (1). Those are documents that name the term, not proof that any of these filers is the business in the search.

The wording suggests a business based in Indonesia. Companies there file with Indonesia Stock Exchange (IDX) and the Financial Services Authority (OJK) rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “electronic” is therefore the Indonesia regulator or exchange site, where annual reports and stock-exchange announcements are published.

In the 9 most relevant full-text hits returned for “Pt electronic city indonesia tbk”, filings range from 2014-01-24 to 2015-08-25. The filers whose documents mention it most often are iSHARES TRUST (CIK 0001100663) (4 hits); MATTHEWS INTERNATIONAL FUNDS (CIK 0000923184) (2 hits); MORGAN STANLEY ASIA-PACIFIC FUND, INC. (CIK 0000919808) (1 hit); DREYFUS PREMIER INVESTMENT FUNDS INC (CIK 0000881773) (1 hit). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 135 entities whose registered name contains the word “electronic”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “electronic” 135, “city” 481, “indonesia” 36. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “electronic” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Pt island concepts indonesia tbk bullish and bearish analyst opinions

“PT … Tbk” is the Indonesian form for a public limited company (Perseroan Terbatas Terbuka), the label used by companies listed on IDX. The name “Pt island concepts indonesia tbk” therefore points to a company organised in Indonesia, and its official disclosures are on the Indonesia Stock Exchange (IDX) company-announcement system, supervised by OJK (www.idx.co.id), not on EDGAR.

No SEC filer could be matched to “Pt island concepts indonesia tbk bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Pt island concepts indonesia tbk” appears in 30 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “island” (search terms considered: island, concepts, indonesia).

A broader EDGAR full-text search for the shorter phrase “Pt island concepts” finds 33 filing documents; among the top 33, the filers mentioning it most are Island Residences Club, Inc. (CIK 0001181277) (29); Meridian Pacific Investments HK Ltd (CIK 0001323046) (3); Island Residence Club, Inc. (CIK 0001181277) (2). Those are documents that name the term, not proof that any of these filers is the business in the search.

The wording suggests a business based in Indonesia. Companies there file with Indonesia Stock Exchange (IDX) and the Financial Services Authority (OJK) rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “island” is therefore the Indonesia regulator or exchange site, where annual reports and stock-exchange announcements are published.

In the 30 most relevant full-text hits returned for “Pt island concepts indonesia tbk”, filings range from 2005-04-04 to 2008-10-31. The filers whose documents mention it most often are Island Residences Club, Inc. (CIK 0001181277) (27 hits); Meridian Pacific Investments HK Ltd (CIK 0001323046) (3 hits); Island Residence Club, Inc. (CIK 0001181277) (2 hits); REGENCY PROPERTY GROUP, INC. (CIK 0001181277) (1 hit). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 197+ entities whose registered name contains the word “island”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “island” 490, “concepts” 260, “indonesia” 36. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “island” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Quanterix corporation bullish and bearish analyst opinions

For “Quanterix corporation bullish and bearish analyst opinions”, the matching SEC registrant is Quanterix Corp, which trades as QTRX and files under Central Index Key 1503274. EDGAR puts it in the “Laboratory Analytical Instruments” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-16, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-02 by Quanterix Corp (CIK 1503274) — source document:

Multi-plexing biomarker analysis in tissue samples with our “Spatial Biology” platforms enables scientists to understand the localized interactions occurring on the cellular level. We believe our combination of technologies will enable scientists to help drive diagnostic innovation in the evolving healthcare landscape with data across the tissue to fluid continuum. Currently, the ability of our Simoa platforms to detect proteins in the femtomolar range is enabling the development of novel therapies and diagnostics and has the potential to identify early-stage disease markers before symptoms appear. We sell our proprietary instruments and related consumables worldwide to research laboratories, contract research organizations ("CROs"), academic institutions, and bio-pharmaceutical companies. In addition, we provide contract research services and clinical laboratory testing services, including four Laboratory Developed Tests ("LDTs"), using our proprietary technology and platforms through our Accelerator Laboratory, which is certified under the Clinical Laboratory Improvement Amendments of 1988 ("CLIA"), located in Bedford, Massachusetts (the "Accelerator Laboratory").

Financial trend for Quanterix Corp from annual reports, periods 2023-09-30 to 2025-12-31: net income (loss) went from -$28.35 million (2023-12-31) to -$107.15 million (2025-12-31), a change of -277.9%; total assets went from $429.22 million (2023-09-30) to $418.77 million (2025-12-31), a change of -2.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1503274, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Quanterix Corp did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Quanterix Corp (CIK 1503274) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-10, and the most recent 10-K annual report was filed 2026-03-02. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 116 8-K or 6-K reports in Quanterix Corp’s recent EDGAR index, the 4 listed here run from 2026-05-26 to 2026-08-10, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1503274 is on the EDGAR company page; the latest 10-K there is dated 2026-03-02 and the oldest filing in the recent index dates from 2018-06-05. Insider trades for Quanterix Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Quartzsea acquisition corporation units bullish and bearish analyst opinions

For “Quartzsea acquisition corporation units bullish and bearish analyst opinions”, the matching SEC registrant is Quartzsea Acquisition Corp, which trades as QSEA, QSEAR, QSEAU and files under Central Index Key 2047455. EDGAR puts it in the “Blank Checks” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-20, across 77 filings on record. This is reference material, not trading advice.

On March 17, 2025, the Company and the Sponsor entered into the Second Amendment to the Subscription Agreement, pursuant to which the purchased amount of Founder Shares was adjusted to 2,898,000, of which 378,000 are subject to forfeiture. As a result of the underwriter’s full exercise of its over-allotment option on March 19, 2025, no shares are subject to forfeiture. On March 19, 2025, the Company consummated its initial public offering (the “IPO”) of 7,200,000 units (the “Units”). Each Unit consists of one ordinary share, par value $0.0001 per share, of the Company (the “Ordinary Shares”) and one-fifth (1/5) of one right to receive one Ordinary Share upon the consummation of the Company’s initial business combination.

Updated Oct 25, 2026 ET

Rallybio corporation bullish and bearish analyst opinions

For “Rallybio corporation bullish and bearish analyst opinions”, the matching SEC registrant is Rallybio Corp, which trades as RLYB and files under Central Index Key 1739410. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation; its earlier registered name was Rallybio Holdings, LLC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-20 (this view begins at filings dated on or before 2026-09-28), across 295 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-16 by Rallybio Corp (CIK 1739410) (passage 2, continuing from the earlier excerpt) — source document:

Upon the terms and subject to the satisfaction of the conditions described in the Merger Agreement, Merger Sub will be merged with and into Candid, with Candid surviving as a wholly owned subsidiary of Rallybio (the “Merger”). The Merger is intended to qualify as a tax-free reorganization for U.S. federal income tax purposes. Concurrently with the execution and delivery of the Merger Agreement, certain investors entered into subscription agreements with Candid, pursuant to which such investors have agreed to purchase, immediately prior to the Merger, shares of Candid common stock representing an aggregate commitment of approximately $505.5 million in the concurrent financing (the “Concurrent Financing”). The shares of Candid common stock that are issued in the Concurrent Financing will be or will have the right to be, respectively, converted into shares of Rallybio Common Stock, par value $0.0001 per share ("Rallybio Common Stock), in the Merger.

Financial trend for Rallybio Corp from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: revenue went from $212,000 (2025-09-30) to $0 (2026-06-30), a change of -100.0%; net income (loss) went from $16.02 million (2025-09-30) to $43.66 million (2026-06-30), a change of +172.6%; total assets went from $67.66 million (2025-09-30) to $98.06 million (2026-06-30), a change of +44.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1739410, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures Rallybio Corp did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Rallybio Corp (CIK 1739410) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2025-11-06, and the most recent 10-K annual report was filed 2026-03-16. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 49 8-K or 6-K reports in Rallybio Corp’s recent EDGAR index, the 4 listed here run from 2025-08-29 to 2026-03-02, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1739410 is on the EDGAR company page; the latest 10-K there is dated 2026-03-16 and the oldest filing in the recent index dates from 2018-05-07. One example from this record is the S-4/A filed 2026-10-14 (document). Insider trades for Rallybio Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Rani zim shopping centers ltd bullish and bearish analyst opinions

The legal-form ending in “Rani zim shopping centers ltd” is the clue: “Limited” is the company form used across Hong Kong, Australia, Singapore and other Commonwealth markets. A company of that kind reports in a Commonwealth jurisdiction (most often Hong Kong, Australia, Singapore or Canada), so the place to read its annual report and announcements is that market’s exchange filing system (HKEXnews, ASX announcements, SGXNet or SEDAR+) — www.hkexnews.hk.

No SEC filer could be matched to “Rani zim shopping centers ltd bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Rani zim shopping centers ltd” appears in 1167+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “rani” (search terms considered: rani, zim, shopping, centers).

A broader EDGAR full-text search for the shorter phrase “Rani zim shopping” finds 1167+ filing documents; among the top 100, the filers mentioning it most are Dimensional ETF Trust (CIK 0001816125) (35); DFA INVESTMENT DIMENSIONS GROUP INC (CIK 0000355437) (14); DFA INVESTMENT TRUST CO (CIK 0000896162) (11). Those are documents that name the term, not proof that any of these filers is the business in the search.

In the 100 most relevant full-text hits returned for “Rani zim shopping centers ltd”, filings range from 2020-02-28 to 2026-09-24. The filers whose documents mention it most often are DFA INVESTMENT DIMENSIONS GROUP INC (CIK 0000355437) (28 hits); Dimensional ETF Trust (CIK 0001816125) (16 hits); DFA INVESTMENT TRUST CO (CIK 0000896162) (11 hits); HARBOR FUNDS (CIK 0000793769) (10 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 13 entities whose registered name contains the word “rani”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “rani” 13, “zim” 5, “shopping” 109, “centers” 419. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “rani” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Repositrak, inc. bullish and bearish analyst opinions

For “Repositrak, inc. bullish and bearish analyst opinions”, the matching SEC registrant is ReposiTrak, Inc., which trades as TRAK and files under Central Index Key 50471. EDGAR puts it in the “Services-Computer Processing & Data Preparation” industry code with NV as its state or country of incorporation; its earlier registered name was PARK CITY GROUP INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a DEFA14A filed 2026-10-05, across 1001 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-09-28 by ReposiTrak, Inc. (CIK 50471) — source document:

ReposiTrak, Inc., a Nevada corporation (“ ReposiTrak ”, “ We ”, “ us ”, “our” or the “ Company ”) is a Software-as-a-Service (“ SaaS ”) company that operates a business-to-business (‘B2B’) e-commerce, compliance, traceability and supply chain management platform. The platform enables retailers, wholesalers, distributors and their suppliers to (a) manage supply chain programs, including out-of-stock management and scan-based trading; (b) manage compliance documents and data and support compliance with traceability requirements; and (c) improve product ordering and forecasting to increase supply chain efficiency and manage risk. Recent Developments Dividend Payment On June 18, 2026, the Board of Directors declared a quarterly cash dividend of $0.02 per share, payable to shareholders of record on June 30, 2026, which was paid on or about August 14, 2026.

Financial trend for ReposiTrak, Inc. from annual reports, periods 2023-06-30 to 2026-06-30: net income (loss) went from $5.59 million (2023-06-30) to $7.57 million (2026-06-30), a change of +35.4%; total assets went from $50.58 million (2023-06-30) to $60.86 million (2026-06-30), a change of +20.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 50471, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures ReposiTrak, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on ReposiTrak, Inc. (CIK 50471) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-09-30, and the most recent 10-K annual report was filed 2026-09-28. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 237 8-K or 6-K reports in ReposiTrak, Inc.’s recent EDGAR index, the 4 listed here run from 2026-06-18 to 2026-09-30, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 50471 is on the EDGAR company page; the latest 10-K there is dated 2026-09-28 and the oldest filing in the recent index dates from 2002-07-30. Insider trades for ReposiTrak, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Scansource, inc. bullish and bearish analyst opinions

For “Scansource, inc. bullish and bearish analyst opinions”, the matching SEC registrant is SCANSOURCE, INC., which trades as SCSC and files under Central Index Key 918965. EDGAR puts it in the “Wholesale-Computers & Peripheral Equipment & Software” industry code with an unstated jurisdiction as its state or country of incorporation; its earlier registered name was SCANSOURCE INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a SCHEDULE 13G/A filed 2026-10-20, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-08-20 by SCANSOURCE, INC. (CIK 918965) — source document:

ScanSource uses multiple sales models to offer technology solutions from leading suppliers of specialty technologies, connectivity and cloud services. The Company operates primarily in the United States and Brazil. We provide technology solutions and services from more than 500 leading suppliers of mobility and barcode, point-of-sale (“POS”), payment terminals, physical security, networking, communications, connectivity and cloud services. The Company's two operating segments, Specialty Technology Solutions and Intelisys & Advisory , represent the different sales models we use in executing our technology growth strategy. ScanSource was incorporated in South Carolina in 1992 and serves approximately 25,000 channel sales partners. Net sales for fiscal year ended June 30, 2026 totaled $3.23 billion . Our common stock trades on the NASDAQ Global Se lect Market under the symbol “SCSC.” Our channel sales partners include businesses of all sizes that sell to end users across many industries.

Financial trend for SCANSOURCE, INC. from annual reports, periods 2023-06-30 to 2026-06-30: net income (loss) went from $89.81 million (2023-06-30) to $78.87 million (2026-06-30), a change of -12.2%; total assets went from $2.07 billion (2023-06-30) to $1.93 billion (2026-06-30), a change of -6.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 918965, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures SCANSOURCE, INC. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on SCANSOURCE, INC. (CIK 918965) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-20, and the most recent 10-K annual report was filed 2026-08-20. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 161 8-K or 6-K reports in SCANSOURCE, INC.’s recent EDGAR index, the 4 listed here run from 2026-05-29 to 2026-09-02, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 918965 is on the EDGAR company page; the latest 10-K there is dated 2026-08-20 and the oldest filing in the recent index dates from 2009-10-08. Insider trades for SCANSOURCE, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Scienture holdings, inc. bullish and bearish analyst opinions

For “Scienture holdings, inc. bullish and bearish analyst opinions”, the matching SEC registrant is Scienture Holdings, Inc., which trades as SCNX and files under Central Index Key 1382574. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation; its earlier registered name was TRxADE HEALTH, INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-19, across 506 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-30 by Scienture Holdings, Inc. (CIK 1382574) — source document:

This information included in this Annual Report should be read in conjunction with the consolidated financial statements and related notes in “ Item 8. Financial Statements and Supplemental Data ” of this Annual Report. Our logo and some of our trademarks and tradenames are used in this Annual Report. This Annual Report may also include trademarks, tradenames and service marks that are the property of others. Solely for convenience, trademarks, tradenames and service marks referred to in this Annual Report may appear without the ®, ™ and SM symbols. References to our trademarks, tradenames and service marks are not intended to indicate in any way that we will not assert to the fullest extent under applicable law our rights or the rights of the applicable licensors if any, nor that respective owners to other intellectual property rights will not assert, to the fullest extent under applicable law, their rights thereto.

Financial trend for Scienture Holdings, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$3.47 million (2022-12-31) to -$41.51 million (2025-12-31), a change of -1095.6%; total assets went from $3.71 million (2022-12-31) to $84.18 million (2025-12-31), a change of +2168.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1382574, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Scienture Holdings, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Scienture Holdings, Inc. (CIK 1382574) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-10-19, and the most recent 10-K annual report was filed 2026-03-30. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 157 8-K or 6-K reports in Scienture Holdings, Inc.’s recent EDGAR index, the 4 listed here run from 2026-08-20 to 2026-10-19, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1382574 is on the EDGAR company page; the latest 10-K/A there is dated 2026-04-30 and the oldest filing in the recent index dates from 2007-06-15. Insider trades for Scienture Holdings, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Scully royalty ltd. bullish and bearish analyst opinions

For “Scully royalty ltd. bullish and bearish analyst opinions”, the matching SEC registrant is Scully Royalty Ltd., which trades as SRL and files under Central Index Key 16859. EDGAR puts it in the “Mineral Royalty Traders” industry code with Cayman Islands as its state or country of incorporation; its earlier registered name was MFC BANCORP LTD.. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-06, across 537 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2025-04-30 by Scully Royalty Ltd. (CIK 16859) — source document:

Unless the context otherwise indicates, references herein to “we”, “us”, “our” or the “Company” are to Scully Royalty Ltd. and its consolidated subsidiaries. CURRENCY INFORMATION The following table sets forth the exchange rates for the translation of United States dollars to Canadian dollars in effect at the end of each of the three most recent financial years. Due to rounding, numbers presented throughout this document may not add up precisely to the totals we provide and percentages may not precisely reflect the absolute figures. Our management uses EBITDA as a measure of our operating results and considers it to be a meaningful supplement to net income as a performance measurement, primarily because we incur significant depreciation and EBITDA eliminates the non-cash impact. ​ EBITDA is used by investors and analysts for the purpose of valuing an issuer.

Financial trend for Scully Royalty Ltd. from annual reports, periods 2021-12-31 to 2024-12-31: revenue went from 71,291,000 CAD (2021-12-31) to 35,302,000 CAD (2024-12-31), a change of -50.5%; net income (loss) went from 7,371,000 CAD (2021-12-31) to -20,268,000 CAD (2024-12-31), a change of -375.0%; total assets went from 509,966,000 CAD (2021-12-31) to 438,095,000 CAD (2024-12-31), a change of -14.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 16859, tags Assets, ProfitLoss, Revenue; 4 periods shown, dashes mark figures Scully Royalty Ltd. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Scully Royalty Ltd. (CIK 16859) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2025-04-30. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 279 8-K or 6-K reports in Scully Royalty Ltd.’s recent EDGAR index, the 4 listed here run from 2026-08-14 to 2026-10-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 16859 is on the EDGAR company page; the latest 20-F there is dated 2025-04-30 and the oldest filing in the recent index dates from 1996-06-17. Insider trades for Scully Royalty Ltd. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Seacoast banking corporation of florida bullish and bearish analyst opinions

For “Seacoast banking corporation of florida bullish and bearish analyst opinions”, the matching SEC registrant is SEACOAST BANKING CORP OF FLORIDA, which trades as SBCF and files under Central Index Key 730708. EDGAR puts it in the “State Commercial Banks” industry code with FL as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-09, across 1003 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-27 by SEACOAST BANKING CORP OF FLORIDA (CIK 730708) — source document:

Seacoast Banking Corporation of Florida (“Seacoast” or the “Company”) is a financial holding company, incorporated in Florida in 1983, and registered under the Bank Holding Company Act of 1956, as amended (the “BHC Act”). Its principal subsidiary is Seacoast National Bank, a wholly-owned national banking association (“Seacoast Bank”) chartered in 1926. As of December 31, 2025, Seacoast had total consolidated assets of $20.8 billion, total deposits of $16.3 billion, total consolidated liabilities, including deposits, of $17.8 billion, consolidated convertible preferred stock of $0.3 billion, and consolidated shareholders’ equity of $2.7 billion. Seacoast Bank is one of the largest banks headquartered in Florida, with an expanding presence in the state's fastest growing markets, each of which has unique characteristics and opportunities.

Financial trend for SEACOAST BANKING CORP OF FLORIDA from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $380.49 million (2022-12-31) to $836.37 million (2025-12-31), a change of +119.8%; net income (loss) went from $106.51 million (2022-12-31) to $144.88 million (2025-12-31), a change of +36.0%; total assets went from $12.15 billion (2022-12-31) to $20.84 billion (2025-12-31), a change of +71.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 730708, tags Assets, InterestAndDividendIncomeOperating, NetIncomeLoss; 4 periods shown, dashes mark figures SEACOAST BANKING CORP OF FLORIDA did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on SEACOAST BANKING CORP OF FLORIDA (CIK 730708) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-07-28, and the most recent 10-K annual report was filed 2026-02-27. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 146 8-K or 6-K reports in SEACOAST BANKING CORP OF FLORIDA’s recent EDGAR index, the 4 listed here run from 2026-05-20 to 2026-09-09, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 730708 is on the EDGAR company page; the latest 10-K there is dated 2026-02-27 and the oldest filing in the recent index dates from 2017-04-24. Insider trades for SEACOAST BANKING CORP OF FLORIDA appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Sequans communications s.a. bullish and bearish analyst opinions

For “Sequans communications s.a. bullish and bearish analyst opinions”, the matching SEC registrant is SEQUANS COMMUNICATIONS, which trades as SQNS and files under Central Index Key 1383395. EDGAR puts it in the “Semiconductors & Related Devices” industry code with France as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-09-24, across 536 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-05-11 by SEQUANS COMMUNICATIONS (CIK 1383395) — source document:

Our History Sequans Communications S.A. was incorporated as a société anonyme under the laws of the French Republic on October 7, 2003, for a period of 99 years. We are registered at the Nanterre Commerce and Companies Register under the number 450 249 677. Our principal executive offices are located at 15-55 boulevard Charles de Gaulle, 92700 Colombes, France, and our telephone number is +33 1 70 72 16 00. Our agent for service of process in the U.S. is GKL Corporate/Search, Inc., One Capitol Mall, Suite 660, Sacramento, California 95814. In June 2025, we raised approximately $384 million through private placements involving equity, warrants, and $189 million in secured convertible debentures.

Financial trend for SEQUANS COMMUNICATIONS from annual reports, periods 2021-12-31 to 2024-12-31: net income (loss) went from -$20.26 million (2021-12-31) to $57.57 million (2024-12-31), a change of +384.1%; total assets went from $89.56 million (2021-12-31) to $106.53 million (2024-12-31), a change of +18.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1383395, tags Assets, ProfitLoss, Revenue; 4 periods shown, dashes mark figures SEQUANS COMMUNICATIONS did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on SEQUANS COMMUNICATIONS (CIK 1383395) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-05-11. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 222 8-K or 6-K reports in SEQUANS COMMUNICATIONS’s recent EDGAR index, the 4 listed here run from 2026-06-30 to 2026-09-24, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1383395 is on the EDGAR company page; the latest 20-F there is dated 2026-05-11 and the oldest filing in the recent index dates from 2011-03-22. Insider trades for SEQUANS COMMUNICATIONS appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Shattuck labs, inc. bullish and bearish analyst opinions

For “Shattuck labs, inc. bullish and bearish analyst opinions”, the matching SEC registrant is Shattuck Labs, Inc., which trades as STTK and files under Central Index Key 1680367. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation; its earlier registered name was Shattuck Labs, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a SCHEDULE 13G/A filed 2026-08-14, across 410 filings on record. This is reference material, not trading advice.

Financial trend for Shattuck Labs, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $652,000 (2022-12-31) to $1.00 million (2025-12-31), a change of +53.4%; net income (loss) went from -$101.94 million (2022-12-31) to -$48.81 million (2025-12-31), a change of +52.1%; total assets went from $205.32 million (2022-12-31) to $91.03 million (2025-12-31), a change of -55.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1680367, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Shattuck Labs, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Shattuck Labs, Inc. (CIK 1680367) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-11, and the most recent 10-K annual report was filed 2026-03-05. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 48 8-K or 6-K reports in Shattuck Labs, Inc.’s recent EDGAR index, the 4 listed here run from 2026-06-02 to 2026-08-11, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 410 recent EDGAR filings, Shattuck Labs, Inc. most often filed 4 (190), 8-K (48), 3 (21), 10-Q (18). A selection from 2026-07-07 to 2026-08-14:

The full record for CIK 1680367 is on the EDGAR company page; the latest 10-K there is dated 2026-03-05 and the oldest filing in the recent index dates from 2016-07-28. Insider trades for Shattuck Labs, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Shenandoah telecommunications company bullish and bearish analyst opinions

For “Shenandoah telecommunications company bullish and bearish analyst opinions”, the matching SEC registrant is SHENANDOAH TELECOMMUNICATIONS CO/VA/, which trades as SHEN and files under Central Index Key 354963. EDGAR puts it in the “Telephone Communications (No Radiotelephone)” industry code with VA as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-22, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-26 by SHENANDOAH TELECOMMUNICATIONS CO/VA/ (CIK 354963) — source document:

Shenandoah Telecommunications Company and its subsidiaries (“Shentel”, “we”, “our”, “us”, or the “Company”), provide broadband services through its high speed, state-of-the-art fiber-optic and cable networks to customers in eight contiguous states in the eastern United States. The Company’s services include: broadband internet, video and voice; high-speed Ethernet, dark fiber leasing; and managed network services. The Company owns an extensive regional network with approximately 19,000 route miles of fiber. For more information, please visit www.shentel.com. Description of Business Shentel provides broadband data, video and voice services to residential and commercial customers in portions of Virginia, West Virginia, Maryland, Pennsylvania, Kentucky, Delaware, Ohio and Indiana, via fiber optic and hybrid fiber coaxial (“HFC”) cable networks.

Financial trend for SHENANDOAH TELECOMMUNICATIONS CO/VA/ from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $248.91 million (2022-12-31) to $357.85 million (2025-12-31), a change of +43.8%; net income (loss) went from -$8.38 million (2022-12-31) to -$32.94 million (2025-12-31), a change of -293.2%; total assets went from $977.72 million (2022-12-31) to $1.91 billion (2025-12-31), a change of +95.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 354963, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures SHENANDOAH TELECOMMUNICATIONS CO/VA/ did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on SHENANDOAH TELECOMMUNICATIONS CO/VA/ (CIK 354963) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-07-29, and the most recent 10-K annual report was filed 2026-02-26. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 71 8-K or 6-K reports in SHENANDOAH TELECOMMUNICATIONS CO/VA/’s recent EDGAR index, the 4 listed here run from 2026-06-08 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 354963 is on the EDGAR company page; the latest 10-K there is dated 2026-02-26 and the oldest filing in the recent index dates from 2020-01-09. Insider trades for SHENANDOAH TELECOMMUNICATIONS CO/VA/ appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Silexion therapeutics ltd. bullish and bearish analyst opinions

For “Silexion therapeutics ltd. bullish and bearish analyst opinions”, the matching SEC registrant is Silexion Therapeutics Corp, which trades as SLXN, SLXNW and files under Central Index Key 2022416. EDGAR puts it in the “Biological Products, (No Diagnostic Substances)” industry code with Cayman Islands as its state or country of incorporation; its earlier registered name was Biomotion Sciences. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a DEFA14A filed 2026-10-19, across 277 filings on record. This is reference material, not trading advice.

Financial trend for Silexion Therapeutics Corp from annual reports, periods 2023-12-31 to 2025-12-31: revenue went from $153,000 (2023-12-31) to $155,000 (2025-12-31), a change of +1.3%; net income (loss) went from -$5.11 million (2023-12-31) to -$11.91 million (2025-12-31), a change of -133.2%; total assets went from $5.26 million (2023-12-31) to $7.21 million (2025-12-31), a change of +37.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2022416, tags Assets, InterestAndDividendIncomeOperating, NetIncomeLoss; 3 periods shown, dashes mark figures Silexion Therapeutics Corp did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Silexion Therapeutics Corp (CIK 2022416) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-14, and the most recent 10-K annual report was filed 2026-03-17. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 81 8-K or 6-K reports in Silexion Therapeutics Corp’s recent EDGAR index, the 4 listed here run from 2026-09-25 to 2026-09-30, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 277 recent EDGAR filings, Silexion Therapeutics Corp most often filed 8-K (81), 424B3 (26), 4 (18), EFFECT (15). A selection from 2026-09-25 to 2026-10-19:

The full record for CIK 2022416 is on the EDGAR company page; the latest 10-K/A there is dated 2026-05-19 and the oldest filing in the recent index dates from 2024-05-09. Insider trades for Silexion Therapeutics Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Silgan holdings inc. bullish and bearish analyst opinions

For “Silgan holdings inc. bullish and bearish analyst opinions”, the matching SEC registrant is SILGAN HOLDINGS INC, which trades as SLGN and files under Central Index Key 849869. EDGAR puts it in the “Metal Cans” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-20, across 1001 filings on record. This is reference material, not trading advice.

Financial trend for SILGAN HOLDINGS INC from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from $340.85 million (2022-12-31) to $288.40 million (2025-12-31), a change of -15.4%; total assets went from $7.35 billion (2022-12-31) to $9.40 billion (2025-12-31), a change of +27.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 849869, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures SILGAN HOLDINGS INC did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on SILGAN HOLDINGS INC (CIK 849869) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-07-29, and the most recent 10-K annual report was filed 2026-02-26. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 244 8-K or 6-K reports in SILGAN HOLDINGS INC’s recent EDGAR index, the 4 listed here run from 2026-08-04 to 2026-10-20, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 1001 recent EDGAR filings, SILGAN HOLDINGS INC most often filed 4 (433), 8-K (244), 10-Q (47), SC 13G/A (43). A selection from 2026-06-26 to 2026-10-15:

The full record for CIK 849869 is on the EDGAR company page; the latest 10-K there is dated 2026-02-26 and the oldest filing in the recent index dates from 2011-04-13. Insider trades for SILGAN HOLDINGS INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Sintx technologies, inc. bullish and bearish analyst opinions

For “Sintx technologies, inc. bullish and bearish analyst opinions”, the matching SEC registrant is Sintx Technologies, Inc., which trades as SINT and files under Central Index Key 1269026. EDGAR puts it in the “Surgical & Medical Instruments & Apparatus” industry code with DE as its state or country of incorporation; its earlier registered name was AMEDICA CORP. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-09, across 657 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-20 by Sintx Technologies, Inc. (CIK 1269026) — source document:

SINTX Technologies SINTX Technologies is an advanced ceramics company formed in December 1996 that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. SINTX provides biomedical solutions for medical devices specializing in silicon nitride (Si₃N₄) for musculoskeletal and antipathogenic applications. We also manufacture parts made from silicon nitride for customers in the electrical, aerospace and other industrial sectors. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans since 2008. SINTX Core Business Biomedical Applications : Since its inception, SINTX has been focused on medical grade silicon nitride. SINTX biomedical products have been shown to be biocompatible, bioactive, antipathogenic, and to have superb bone affinity.

Financial trend for Sintx Technologies, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $1.56 million (2022-12-31) to $1.02 million (2025-12-31), a change of -34.8%; net income (loss) went from -$12.04 million (2022-12-31) to -$10.36 million (2025-12-31), a change of +13.9%; total assets went from $15.77 million (2022-12-31) to $9.51 million (2025-12-31), a change of -39.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1269026, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Sintx Technologies, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Sintx Technologies, Inc. (CIK 1269026) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-10-01, and the most recent 10-K annual report was filed 2026-03-20. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 203 8-K or 6-K reports in Sintx Technologies, Inc.’s recent EDGAR index, the 4 listed here run from 2026-08-11 to 2026-10-09, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1269026 is on the EDGAR company page; the latest 10-K there is dated 2026-03-20 and the oldest filing in the recent index dates from 2003-11-03. Insider trades for Sintx Technologies, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Siteone landscape supply, inc. bullish and bearish analyst opinions

For “Siteone landscape supply, inc. bullish and bearish analyst opinions”, the matching SEC registrant is SiteOne Landscape Supply, Inc., which trades as SITE and files under Central Index Key 1650729. EDGAR puts it in the “Wholesale-Professional & Commercial Equipment & Supplies” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-08-28, across 850 filings on record. This is reference material, not trading advice.

Financial trend for SiteOne Landscape Supply, Inc. from annual reports, periods 2023-01-01 to 2025-12-28: revenue went from $4.01 billion (2023-01-01) to $4.70 billion (2025-12-28), a change of +17.2%; net income (loss) went from $245.40 million (2023-01-01) to $151.80 million (2025-12-28), a change of -38.1%; total assets went from $2.53 billion (2023-01-01) to $3.22 billion (2025-12-28), a change of +27.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1650729, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures SiteOne Landscape Supply, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on SiteOne Landscape Supply, Inc. (CIK 1650729) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-07-29, and the most recent 10-K annual report was filed 2026-02-19. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 101 8-K or 6-K reports in SiteOne Landscape Supply, Inc.’s recent EDGAR index, the 4 listed here run from 2026-04-27 to 2026-07-29, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 850 recent EDGAR filings, SiteOne Landscape Supply, Inc. most often filed 4 (504), 8-K (101), SC 13G/A (37), 10-Q (32). A selection from 2026-07-29 to 2026-08-28:

The full record for CIK 1650729 is on the EDGAR company page; the latest 10-K there is dated 2026-02-19 and the oldest filing in the recent index dates from 2015-08-18. Insider trades for SiteOne Landscape Supply, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Smartkem, inc. bullish and bearish analyst opinions

For “Smartkem, inc. bullish and bearish analyst opinions”, the matching SEC registrant is SmartKem, Inc., which trades as SMTK and files under Central Index Key 1817760. EDGAR puts it in the “Semiconductors & Related Devices” industry code with DE as its state or country of incorporation; its earlier registered name was Parasol Investments Corp. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-09-21, across 350 filings on record. This is reference material, not trading advice.

Financial trend for SmartKem, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $40,000 (2022-12-31) to $697,000 (2025-12-31), a change of +1642.5%; net income (loss) went from -$11.49 million (2022-12-31) to -$10.51 million (2025-12-31), a change of +8.6%; total assets went from $7.53 million (2022-12-31) to $2.29 million (2025-12-31), a change of -69.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1817760, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures SmartKem, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on SmartKem, Inc. (CIK 1817760) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2025-11-13, and the most recent 10-K annual report was filed 2026-04-08. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 77 8-K or 6-K reports in SmartKem, Inc.’s recent EDGAR index, the 4 listed here run from 2026-08-21 to 2026-09-21, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 350 recent EDGAR filings, SmartKem, Inc. most often filed 8-K (77), 4 (58), 424B3 (35), 10-Q (19). A selection from 2026-07-27 to 2026-09-18:

The full record for CIK 1817760 is on the EDGAR company page; the latest 10-K there is dated 2026-04-08 and the oldest filing in the recent index dates from 2020-07-13. Insider trades for SmartKem, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Soren acquisition corp. bullish and bearish analyst opinions

For “Soren acquisition corp. bullish and bearish analyst opinions”, the matching SEC registrant is Soren Acquisition Corp., which trades as SORN, SORNU, SORNW and files under Central Index Key 2086263. EDGAR puts it in the “Blank Checks” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a SCHEDULE 13G/A filed 2026-08-13, across 28 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-27 by Soren Acquisition Corp. (CIK 2086263) — source document:

We are a blank check company incorporated on September 2, 2025 as a Cayman Islands exempted company and formed for the purpose of effecting a Business Combination with one or more businesses or entities. To date, we have not selected any Business Combination target, and our efforts have been limited to (i) organizational activities, (ii) activities related to our Initial Public Offering, and (iii) searching for a Business Combination target. We have also generated no operating revenues to date and we do not expect that we will generate operating revenues until we consummate our initial Business Combination. Although we currently intend to focus on target businesses in the healthcare industry, we may pursue an initial Business Combination target in any business, industry, sector or geographical location.

Financial trend for Soren Acquisition Corp. from quarterly and annual reports (three-month periods), periods 2026-03-31 to 2026-06-30: net income (loss) went from $1.68 million (2026-03-31) to $2.03 million (2026-06-30), a change of +20.8%; total assets went from $257.25 million (2026-03-31) to $259.29 million (2026-06-30), a change of +0.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2086263, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures Soren Acquisition Corp. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Soren Acquisition Corp. (CIK 2086263) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-03-27. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for Soren Acquisition Corp. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 3 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2026-01-08.

Current reports. Of the 3 8-K or 6-K reports in Soren Acquisition Corp.’s recent EDGAR index, the 3 listed here run from 2026-01-09 to 2026-02-26, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2086263 is on the EDGAR company page; the latest 10-K there is dated 2026-03-27 and the oldest filing in the recent index dates from 2025-10-08. Insider trades for Soren Acquisition Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Spero therapeutics, inc. bullish and bearish analyst opinions

For “Spero therapeutics, inc. bullish and bearish analyst opinions”, the matching SEC registrant is Spero Therapeutics, Inc., which trades as SPRO and files under Central Index Key 1701108. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation; its earlier registered name was Spero Therapeutics, LLC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a EFFECT filed 2026-09-10, across 513 filings on record. This is reference material, not trading advice.

Financial trend for Spero Therapeutics, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $53.51 million (2022-12-31) to $66.80 million (2025-12-31), a change of +24.8%; net income (loss) went from $22.81 million (2023-12-31) to $8.57 million (2025-12-31), a change of -62.4%; total assets went from $124.80 million (2022-12-31) to $68.92 million (2025-12-31), a change of -44.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1701108, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Spero Therapeutics, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Spero Therapeutics, Inc. (CIK 1701108) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-12, and the most recent 10-K annual report was filed 2026-03-26. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 115 8-K or 6-K reports in Spero Therapeutics, Inc.’s recent EDGAR index, the 4 listed here run from 2026-06-25 to 2026-08-28, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1701108 is on the EDGAR company page; the latest 10-K there is dated 2026-03-26 and the oldest filing in the recent index dates from 2017-03-21. Insider trades for Spero Therapeutics, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Spyglass pharma, inc. common stock bullish and bearish analyst opinions

For “Spyglass pharma, inc. common stock bullish and bearish analyst opinions”, the matching SEC registrant is SpyGlass Pharma, Inc., which trades as SGP and files under Central Index Key 1778922. EDGAR puts it in the “Surgical & Medical Instruments & Apparatus” industry code with DE as its state or country of incorporation; its earlier registered name was SpyGlassPharma, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-19, across 92 filings on record. This is reference material, not trading advice.

Financial trend for SpyGlass Pharma, Inc. from annual reports, periods 2024-12-31 to 2025-12-31: net income (loss) went from -$29.16 million (2024-12-31) to -$39.87 million (2025-12-31), a change of -36.7%; total assets went from $23.32 million (2024-12-31) to $115.87 million (2025-12-31), a change of +396.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1778922, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures SpyGlass Pharma, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on SpyGlass Pharma, Inc. (CIK 1778922) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-06, and the most recent 10-K annual report was filed 2026-03-26. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 8 8-K or 6-K reports in SpyGlass Pharma, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-14 to 2026-10-19, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 92 recent EDGAR filings, SpyGlass Pharma, Inc. most often filed 4 (29), 3 (24), 8-K (8), SCHEDULE 13D (4). A selection from 2026-02-17 to 2026-08-06:

The full record for CIK 1778922 is on the EDGAR company page; the latest 10-K there is dated 2026-03-26 and the oldest filing in the recent index dates from 2019-06-05. Insider trades for SpyGlass Pharma, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Star vault ab (publ) bullish and bearish analyst opinions

“AB (publ)” marks a Swedish public limited company (aktiebolag) allowed to offer shares to the public. The name “Star vault ab (publ)” therefore points to a company organised in Sweden, and its official disclosures are on Nasdaq Stockholm / Spotlight announcements and the Swedish FSA (Finansinspektionen) register (www.fi.se), not on EDGAR.

No SEC filer could be matched to “Star vault ab (publ) bullish and bearish analyst opinions” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Star vault ab publ”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “star” (search terms considered: star, vault).

Even the shorter phrase “Star vault ab” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (star, vault) point to a business outside the SEC system or one known by another legal name.

The wording suggests a business based in Sweden. Companies there file with Nasdaq Stockholm and Finansinspektionen rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “star” is therefore the Sweden regulator or exchange site, where annual reports and stock-exchange announcements are published.

EDGAR’s company index has 197+ entities whose registered name contains the word “star”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “star” 482, “vault” 120. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “star” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Starry sea acquisition corp. bullish and bearish analyst opinions

For “Starry sea acquisition corp. bullish and bearish analyst opinions”, the matching SEC registrant is STARRY SEA ACQUISITION CORP, which trades as SSEA, SSEAR, SSEAU and files under Central Index Key 2059165. EDGAR puts it in the “Blank Checks” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K/A filed 2026-10-23, across 68 filings on record. This is reference material, not trading advice.

Our sponsor is Starry Sea Investment Limited, a British Virgin Islands company, which was formed to invest in our company. Although our sponsor is permitted to undertake any activities permitted under British Virgin Islands law and other applicable law, our sponsor’s business is focused on investing in our company. Although each of our officers and directors is a shareholder of our sponsor; only Mr. Guojian Zhang, the sole director of our sponsor, holds voting securities in our sponsor and has the power to vote or dispose of the securities. On February 14, 2025, our sponsor purchased an aggregate of 1,437,500 ordinary shares (up to 187,500 of which were subject to forfeiture by the holders thereof depending on the extent to which the underwriters’ option to purchase additional units is exercised) for an aggregate purchase price of $25,000, or approximately $0.017 per share, and subsequently, an aggregate of 205,000 founder shares transferred were transferred from sponsor to two executive officers and three independent director nominees at nil consideration.

Analyst ratings, price targets and “bullish” or “bearish” calls on STARRY SEA ACQUISITION CORP (CIK 2059165) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-04-02. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Updated Oct 25, 2026 ET

Steakholder foods ltd. bullish and bearish analyst opinions

For “Steakholder foods ltd. bullish and bearish analyst opinions”, the matching SEC registrant is Steakholder Foods Ltd., which trades as STKH, MTTCF and files under Central Index Key 1828098. EDGAR puts it in the “Food and Kindred Products” industry code with Israel as its state or country of incorporation; its earlier registered name was MeaTech 3D Ltd. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a SCHEDULE 13D filed 2026-10-07, across 322 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-04-30 by Steakholder Foods Ltd. (CIK 1828098) — source document:

Operating and Financial Review and Prospects 45 5.A. Operating Results 45 5.B. Liquidity and Capital Resources 49 5.C. Research and Development, Patents and Licenses, etc. 51 5.D. Trend Information 51 5.E. Critical Accounting Estimates 51 ITEM 6. Directors, Senior Management and Employees 52 6.A. Directors and Senior Management 52 6.B. Compensation 53 6.C. Board Practices 59 6.D. Employees 67 6.E. Share Ownership 67 6.F. Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation 67 ITEM 7. Major Shareholders and Related Party Transactions 67 7.A. Major Shareholders 67 7.B. Related Party Transactions 69 7.C. Interest of Experts and Counsel 69 ITEM 8. Financial Information 70 8.A. Consolidated Statements and Other Financial Information 70 8.B. Significant Changes 70 ITEM 9.

Financial trend for Steakholder Foods Ltd. from annual reports, periods 2022-12-31 to 2025-12-31: revenue was tagged only for 2024-12-31 at $10,000; net income (loss) went from -$21.86 million (2022-12-31) to -$11.25 million (2025-12-31), a change of +48.5%; total assets went from $15.80 million (2022-12-31) to $5.29 million (2025-12-31), a change of -66.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1828098, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Steakholder Foods Ltd. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Steakholder Foods Ltd. (CIK 1828098) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-04-30. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 183 8-K or 6-K reports in Steakholder Foods Ltd.’s recent EDGAR index, the 4 listed here run from 2026-09-03 to 2026-10-05, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1828098 is on the EDGAR company page; the latest 20-F there is dated 2026-04-30 and the oldest filing in the recent index dates from 2020-10-27. Insider trades for Steakholder Foods Ltd. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Stealthgas inc. bullish and bearish analyst opinions

For “Stealthgas inc. bullish and bearish analyst opinions”, the matching SEC registrant is StealthGas Inc., which trades as GASS and files under Central Index Key 1328919. EDGAR puts it in the “Deep Sea Foreign Transportation of Freight” industry code with Marshall Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-09-18, across 349 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-04-28 by StealthGas Inc. (CIK 1328919) — source document:

StealthGas Inc. was incorporated in December 2004 in the Republic of the Marshall Islands. Our registered address in the Marshall Islands is Trust Company Complex, Ajeltake Road, Ajeltake Island, Majuro, Marshall Islands MH96960. The name of our registered agent at such address is The Trust Company of the Marshall Islands, Inc. Our principal executive offices are located at 331 Kifissias Avenue, Kifissia 14561 Athens, Greece. Our telephone number for calls originating from the United States is (011) (30) (210) 625-0001. In October 2005, we completed an initial public offering of our common stock in the United States and our common stock began trading on the Nasdaq National Market and now trades on the Nasdaq Global Select Market under the symbol “GASS”.

Financial trend for StealthGas Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $152.76 million (2022-12-31) to $173.16 million (2025-12-31), a change of +13.4%; net income (loss) went from $34.25 million (2022-12-31) to $60.65 million (2025-12-31), a change of +77.1%; total assets went from $821.53 million (2022-12-31) to $711.69 million (2025-12-31), a change of -13.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1328919, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures StealthGas Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on StealthGas Inc. (CIK 1328919) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-04-28. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 149 8-K or 6-K reports in StealthGas Inc.’s recent EDGAR index, the 4 listed here run from 2026-03-03 to 2026-09-03, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1328919 is on the EDGAR company page; the latest 20-F there is dated 2026-04-28 and the oldest filing in the recent index dates from 2005-08-29. Insider trades for StealthGas Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Stellus capital investment corporation bullish and bearish analyst opinions

For “Stellus capital investment corporation bullish and bearish analyst opinions”, the matching SEC registrant is Stellus Capital Investment Corp, which trades as SCM and files under Central Index Key 1551901. EDGAR puts it in the “no SIC description” industry code with MD as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a APP NTC filed 2026-10-14, across 443 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-11 by Stellus Capital Investment Corp (CIK 1551901) — source document:

Except as otherwise indicated, the terms “we,” “us,” “our,” and the “Company” refer to Stellus Capital Investment Corporation; and “Stellus Capital Management,” the “Advisor” or the “Administrator” refer to our investment adviser and administrator, Stellus Capital Management, LLC. General We are an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). We were organized as a Maryland corporation on May 8, 2012, and formally commenced operations on November 7, 2012. We originate and invest primarily in private U.S. lower middle-market companies (typically those with $5 million to $50 million of EBITDA (earnings before interest, taxes, depreciation and amortization)) through first lien (including unitranche), second lien, and unsecured debt financing, often with corresponding equity co-investments.

Financial trend for Stellus Capital Investment Corp from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $72.96 million (2022-12-31) to $97.76 million (2025-12-31), a change of +34.0%; net income (loss) went from $14.49 million (2022-12-31) to $27.05 million (2025-12-31), a change of +86.6%; total assets went from $898.18 million (2022-12-31) to $1.04 billion (2025-12-31), a change of +15.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1551901, tags Assets, InterestAndDividendIncomeOperating, NetIncomeLoss; 4 periods shown, dashes mark figures Stellus Capital Investment Corp did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Stellus Capital Investment Corp (CIK 1551901) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-07-29, and the most recent 10-K annual report was filed 2026-03-11. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 52 8-K or 6-K reports in Stellus Capital Investment Corp’s recent EDGAR index, the 4 listed here run from 2026-02-05 to 2026-07-29, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1551901 is on the EDGAR company page; the latest 10-K there is dated 2026-03-11 and the oldest filing in the recent index dates from 2012-07-20. Insider trades for Stellus Capital Investment Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Sunlands technology group bullish and bearish analyst opinions

For “Sunlands technology group bullish and bearish analyst opinions”, the matching SEC registrant is Sunlands Technology Group, which trades as STG and files under Central Index Key 1723935. EDGAR puts it in the “Services-Educational Services” industry code with Cayman Islands as its state or country of incorporation; its earlier registered name was Sunlands Online Education Group. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-08-20, across 143 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-04-24 by Sunlands Technology Group (CIK 1723935) — source document:

The Group remained an offline, classroom-based education service provider until the Group transitioned to an exclusively online education model in 2014. In September 2015, Sunlands Technology Group (formerly known as “Studyvip Online Education International Limited” and “Sunlands Online Education Group”), our current ultimate holding company, was incorporated under the laws of the Cayman Islands. It was renamed as Sunlands Online Education Group in October 2017, and further renamed as Sunlands Technology Group in August 2018. In October 2015, our wholly-owned subsidiary, Sunlands Online Education HK Limited, or Sunlands HK, was incorporated in Hong Kong. In July 2017, Tianjin Alaman Education Technology Co., Ltd. (formerly known as “Tianjin Studyvip Education Co., Limited”), or Tianjin Alaman, our wholly-owned subsidiary, was incorporated in the PRC. It was renamed as Tianjin Alaman Education Technology Co., Ltd. in February 2021 and was deregistered in March 2024.

Financial trend for Sunlands Technology Group from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from 2,323,101,000 CNY (2022-12-31) to 2,019,881,000 CNY (2025-12-31), a change of -13.1%; net income (loss) went from 643,959,000 CNY (2022-12-31) to 365,631,000 CNY (2025-12-31), a change of -43.2%; total assets went from 2,276,070,000 CNY (2022-12-31) to 2,047,218,000 CNY (2025-12-31), a change of -10.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1723935, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Sunlands Technology Group did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Sunlands Technology Group (CIK 1723935) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-04-24. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 69 8-K or 6-K reports in Sunlands Technology Group’s recent EDGAR index, the 4 listed here run from 2026-04-24 to 2026-08-20, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1723935 is on the EDGAR company page; the latest 20-F there is dated 2026-04-24 and the oldest filing in the recent index dates from 2017-12-13. Insider trades for Sunlands Technology Group appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Sunshine lake pharma co., ltd. bullish and bearish analyst opinions

For “Sunshine lake pharma co., ltd. bullish and bearish analyst opinions”, the matching SEC registrant is Sunshine Lake Pharma Co., Ltd., which trades as none listed and files under Central Index Key 2022329. EDGAR puts it in the “no SIC description” industry code with an unstated jurisdiction as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a CB/A filed 2025-08-07, across 26 filings on record. This is reference material, not trading advice.

Analyst ratings, price targets and “bullish” or “bearish” calls on Sunshine Lake Pharma Co., Ltd. (CIK 2022329) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

What kind of filer this is matters for “Sunshine lake pharma co., ltd. bullish and bearish analyst opinions”: Sunshine Lake Pharma Co., Ltd.’s EDGAR record from 2024-05-13 to 2025-08-07 consists only of CB filings; CB/A filings; F-X filings. It has no 10-K, 10-Q or 20-F, so the SEC holds no audited financial statements or annual business description for it.

Other filings. Across its 26 recent EDGAR filings, Sunshine Lake Pharma Co., Ltd. most often filed CB/A (24), F-X (1), CB (1). A selection from 2025-07-22 to 2025-08-07:

The full record for CIK 2022329 is on the EDGAR company page and the oldest filing in the recent index dates from 2024-05-13. Insider trades for Sunshine Lake Pharma Co., Ltd. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Supercom ltd. bullish and bearish analyst opinions

For “Supercom ltd. bullish and bearish analyst opinions”, the matching SEC registrant is SuperCom Ltd, which trades as SPCB and files under Central Index Key 1291855. EDGAR puts it in the “Semiconductors & Related Devices” industry code with Israel as its state or country of incorporation; its earlier registered name was Vuance Ltd. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-09-30, across 428 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-04-28 by SuperCom Ltd (CIK 1291855) — source document:

OPERATING AND FINANCIAL REVIEW AND PROSPECTS 38 A. Operating Results 38 B. Liquidity and Capital Resources 45 C. Research and Development, Patents and Licenses, etc. 53 D. Trend Information 53 E. Off-Balance Sheet Arrangements 53 F. Tabular Disclosure of Contractual Obligations ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 53 A. Directors and Senior Management 53 B. Compensation 56 C. Board Practices 57 D. Employees 66 E. Share Ownership 67 ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 70 A. Major Shareholders 70 B. Related Party Transactions 71 C. Interests of Experts and Counsel 71 ITEM 8. FINANCIAL INFORMATION 71 A. Consolidated Statements and Other Financial Information 71 B. Significant Changes 72 ITEM 9.

Financial trend for SuperCom Ltd from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $17.65 million (2022-12-31) to $27.90 million (2025-12-31), a change of +58.1%; net income (loss) went from -$7.46 million (2022-12-31) to $3.75 million (2025-12-31), a change of +150.3%; total assets went from $42.04 million (2022-12-31) to $68.38 million (2025-12-31), a change of +62.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1291855, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures SuperCom Ltd did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on SuperCom Ltd (CIK 1291855) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-04-28. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 220 8-K or 6-K reports in SuperCom Ltd’s recent EDGAR index, the 4 listed here run from 2025-05-19 to 2026-09-30, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1291855 is on the EDGAR company page; the latest 20-F there is dated 2026-04-28 and the oldest filing in the recent index dates from 2004-06-07. Insider trades for SuperCom Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Superx ai technology limited bullish and bearish analyst opinions

For “Superx ai technology limited bullish and bearish analyst opinions”, the matching SEC registrant is SuperX AI Technology Ltd, which trades as SUPX and files under Central Index Key 1897087. EDGAR puts it in the “Services-Management Consulting Services” industry code with Virgin Islands, British as its state or country of incorporation; its earlier registered name was Super X AI Technology Ltd. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a SCHEDULE 13G/A filed 2026-10-14, across 177 filings on record. This is reference material, not trading advice.

Financial trend for SuperX AI Technology Ltd from annual reports, periods 2022-06-30 to 2025-06-30: revenue went from $9.62 million (2022-06-30) to $3.60 million (2025-06-30), a change of -62.6%; net income (loss) went from -$65,911 (2022-06-30) to -$21.21 million (2025-06-30), a change of -32086.5%; total assets went from $2.46 million (2023-06-30) to $52.05 million (2025-06-30), a change of +2013.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1897087, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures SuperX AI Technology Ltd did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on SuperX AI Technology Ltd (CIK 1897087) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2025-10-31. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 83 8-K or 6-K reports in SuperX AI Technology Ltd’s recent EDGAR index, the 4 listed here run from 2026-09-03 to 2026-09-30, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 177 recent EDGAR filings, SuperX AI Technology Ltd most often filed 6-K (83), UPLOAD (13), F-1/A (13), 3 (12). A selection from 2026-07-30 to 2026-10-14:

The full record for CIK 1897087 is on the EDGAR company page; the latest 20-F there is dated 2025-10-31 and the oldest filing in the recent index dates from 2021-12-15. Insider trades for SuperX AI Technology Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Sutro biopharma, inc. bullish and bearish analyst opinions

For “Sutro biopharma, inc. bullish and bearish analyst opinions”, the matching SEC registrant is SUTRO BIOPHARMA, INC., which trades as STRO and files under Central Index Key 1382101. EDGAR puts it in the “Biological Products, (No Diagnostic Substances)” industry code with an unstated jurisdiction as its state or country of incorporation; its earlier registered name was SUTRO BIOPHARMA INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-09-22, across 624 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-23 by SUTRO BIOPHARMA, INC. (CIK 1382101) — source document:

We are a clinical stage oncology company developing site-specific and novel-format antibody drug conjugates, or ADCs, enabled by our proprietary integrated cell-free protein synthesis platform, XpressCF ® , and our site-specific conjugation platform, XpressCF+ ® . We aim to design and develop therapeutics using the most relevant and potent modalities, including ADCs, bispecific ADCs, immunostimulatory ADCs, or iADCs, and dual-payload ADCs, or dpADCs. Our molecules are directed primarily against clinically validated targets where the current standard of care is suboptimal. We believe that our platform allows us to accelerate the discovery and development of potential first-in-class and/or best-in-class molecules by enabling the rapid and systematic evaluation of protein structure-activity relationships to create optimized homogeneous product candidates.

Financial trend for SUTRO BIOPHARMA, INC. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$119.20 million (2022-12-31) to -$191.09 million (2025-12-31), a change of -60.3%; total assets went from $406.94 million (2022-12-31) to $173.83 million (2025-12-31), a change of -57.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1382101, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures SUTRO BIOPHARMA, INC. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on SUTRO BIOPHARMA, INC. (CIK 1382101) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-12, and the most recent 10-K annual report was filed 2026-03-23. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 92 8-K or 6-K reports in SUTRO BIOPHARMA, INC.’s recent EDGAR index, the 4 listed here run from 2026-03-23 to 2026-08-12, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1382101 is on the EDGAR company page; the latest 10-K there is dated 2026-03-23 and the oldest filing in the recent index dates from 2006-11-08. Insider trades for SUTRO BIOPHARMA, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Swvl holdings corp. bullish and bearish analyst opinions

For “Swvl holdings corp. bullish and bearish analyst opinions”, the matching SEC registrant is Swvl Holdings Corp, which trades as SWVL, SWVLW and files under Central Index Key 1875609. EDGAR puts it in the “Services-Business Services, NEC” industry code with Virgin Islands, British as its state or country of incorporation; its earlier registered name was Pivotal Holdings Corp. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-08, across 201 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-04-20 by Swvl Holdings Corp (CIK 1875609) — source document:

OPERATING AND FINANCIAL REVIEW AND PROSPECTS 50 ​ ​ ​ ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 67 ​ ​ ​ ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 72 ​ ​ ​ ITEM 8. FINANCIAL INFORMATION 75 ​ ​ ​ ITEM 9. THE OFFER AND LISTING 76 ​ ​ ​ ITEM 10. ADDITIONAL INFORMATION 76 ​ ​ ​ ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 87 ​ ​ ​ ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES 88 ​ ​ ​ PART II 89 ​ ​ ​ ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES 89 ​ ​ ​ ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS 89 ​ ​ ​ ITEM 15.

Financial trend for Swvl Holdings Corp from annual reports, periods 2021-12-31 to 2024-12-31: revenue went from $25.56 million (2021-12-31) to $17.21 million (2024-12-31), a change of -32.7%; net income (loss) went from -$141.49 million (2021-12-31) to -$10.27 million (2024-12-31), a change of +92.7%; total assets went from $59.34 million (2021-12-31) to $16.37 million (2024-12-31), a change of -72.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1875609, tags Assets, ProfitLoss, Revenue; 4 periods shown, dashes mark figures Swvl Holdings Corp did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Swvl Holdings Corp (CIK 1875609) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-04-20. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 78 8-K or 6-K reports in Swvl Holdings Corp’s recent EDGAR index, the 4 listed here run from 2026-09-08 to 2026-10-08, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1875609 is on the EDGAR company page; the latest 20-F there is dated 2026-04-20 and the oldest filing in the recent index dates from 2021-07-30. Insider trades for Swvl Holdings Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Syntec construction public company limited bullish and bearish analyst opinions

Read from its name, “Syntec construction public company limited” is a Thailand entity — “Public Company Limited” is the legal form Thai law requires for companies listed on SET or mai. Its accounts and exchange notices are published through the Stock Exchange of Thailand (SET) company pages and the SEC Thailand filing system (www.set.or.th); the SEC only receives filings from such a company if it sells registered securities in the U.S.

No SEC filer could be matched to “Syntec construction public company limited bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Syntec construction public company limited” appears in 62 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “syntec” (search terms considered: syntec, construction, public).

A broader EDGAR full-text search for the shorter phrase “Syntec construction public” finds 127+ filing documents; among the top 100, the filers mentioning it most are Dimensional ETF Trust (CIK 0001816125) (34); JOHN HANCOCK VARIABLE INSURANCE TRUST (CIK 0000756913) (20); OLD WESTBURY FUNDS INC (CIK 0000909994) (17). Those are documents that name the term, not proof that any of these filers is the business in the search.

In the 62 most relevant full-text hits returned for “Syntec construction public company limited”, filings range from 2015-08-26 to 2024-09-27. The filers whose documents mention it most often are Dimensional ETF Trust (CIK 0001816125) (34 hits); JOHN HANCOCK VARIABLE INSURANCE TRUST (CIK 0000756913) (24 hits); John Hancock Funds II (CIK 0001331971) (4 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 4 entities whose registered name contains the word “syntec”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “syntec” 4, “construction” 405, “public” 466. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “syntec” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

System1 group plc bullish and bearish analyst opinions

“plc” is the UK public limited company form, so the company’s accounts are filed at Companies House. The name “System1 group plc” therefore points to a company organised in the United Kingdom, and its official disclosures are on Companies House and the London Stock Exchange RNS announcements (find-and-update.company-information.service.gov.uk), not on EDGAR.

No SEC filer could be matched to “System1 group plc bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “System1 group plc” appears in 111+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “system1” (search terms considered: system1).

The wording suggests a business based in the United Kingdom. Companies there file with the London Stock Exchange and the FCA National Storage Mechanism rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “system1” is therefore the the United Kingdom regulator or exchange site, where annual reports and stock-exchange announcements are published.

In the 100 most relevant full-text hits returned for “System1 group plc”, filings range from 2017-06-30 to 2026-08-31. The filers whose documents mention it most often are RBB FUND, INC. (CIK 0000831114) (55 hits); Aspiriant Trust (CIK 0001534881) (23 hits); AIM FUNDS GROUP (INVESCO FUNDS GROUP) (CIK 0000019034) (20 hits); JPMorgan Asset Management (UK) Ltd (CIK 0001362941) (2 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 1 entities whose registered name contains the word “system1”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “system1” 1. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “system1” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Takeda ip holdings co.,ltd. bullish and bearish analyst opinions

The legal-form ending in “Takeda ip holdings co.,ltd.” is the clue: “Co., Ltd.” is the English rendering used by limited companies across East Asia. A company of that kind reports in China, Taiwan, Korea or Japan, so the place to read its annual report and announcements is the home-exchange disclosure system (SSE/SZSE in mainland China, MOPS in Taiwan, DART in Korea, EDINET in Japan) — mops.twse.com.tw.

No SEC filer could be matched to “Takeda ip holdings co.,ltd. bullish and bearish analyst opinions” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Takeda ip holdings co.,ltd.”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “takeda” (search terms considered: takeda).

Even the shorter phrase “Takeda ip holdings” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (takeda) point to a business outside the SEC system or one known by another legal name.

EDGAR’s company index has 10 entities whose registered name contains the word “takeda”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “takeda” 10. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “takeda”: TAKEDA A/S (CIK 1716380), TAKEDA EUROPE HOLDINGS B.V. (CIK 1716379), TAKEDA PHARMA A/S (CIK 1716226). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: analyst views on “takeda” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Tbk & sons holdings limited bullish and bearish analyst opinions

Read from its name, “Tbk & sons holdings limited” is a a Commonwealth jurisdiction (most often Hong Kong, Australia, Singapore or Canada) entity — “Limited” is the company form used across Hong Kong, Australia, Singapore and other Commonwealth markets. Its accounts and exchange notices are published through that market’s exchange filing system (HKEXnews, ASX announcements, SGXNet or SEDAR+) (www.hkexnews.hk); the SEC only receives filings from such a company if it sells registered securities in the U.S.

No SEC filer could be matched to “Tbk & sons holdings limited bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Tbk & sons holdings limited” appears in 14 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “sons” (search terms considered: sons).

A broader EDGAR full-text search for the shorter phrase “Tbk sons holdings” finds 14 filing documents; among the top 14, the filers mentioning it most are Rich Sparkle Holdings Ltd (ANPA) (CIK 0002031688) (6); Rich Sparkle Holdings Ltd (CIK 0002031688) (4); Professional Diversity Network, Inc. (IPDN) (CIK 0001546296) (2). Those are documents that name the term, not proof that any of these filers is the business in the search.

The wording suggests a business based in Indonesia. Companies there file with Indonesia Stock Exchange (IDX) and the Financial Services Authority (OJK) rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “sons” is therefore the Indonesia regulator or exchange site, where annual reports and stock-exchange announcements are published.

In the 14 most relevant full-text hits returned for “Tbk & sons holdings limited”, filings range from 2021-09-28 to 2026-04-30. The filers whose documents mention it most often are Rich Sparkle Holdings Ltd (ANPA) (CIK 0002031688) (6 hits); Rich Sparkle Holdings Ltd (CIK 0002031688) (4 hits); Professional Diversity Network, Inc. (IPDN) (CIK 0001546296) (2 hits); CytoMed Therapeutics Pte. Ltd. (GDTC) (CIK 0001873093) (2 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 82 entities whose registered name contains the word “sons”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “sons” 82. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “sons” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Tempest minerals limited bullish and bearish analyst opinions

“Limited” is the company form used across Hong Kong, Australia, Singapore and other Commonwealth markets. The name “Tempest minerals limited” therefore points to a company organised in a Commonwealth jurisdiction (most often Hong Kong, Australia, Singapore or Canada), and its official disclosures are on that market’s exchange filing system (HKEXnews, ASX announcements, SGXNet or SEDAR+) (www.hkexnews.hk), not on EDGAR.

No SEC filer could be matched to “Tempest minerals limited bullish and bearish analyst opinions” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Tempest minerals limited”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “tempest” (search terms considered: tempest, minerals).

EDGAR’s company index has 20 entities whose registered name contains the word “tempest”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “tempest” 20, “minerals” 475. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “tempest”: ARTEMIS FUND SPV 1 TEMPEST LLC (CIK 1853128), BENNELONG TEMPEST FUND LTD (CIK 1553675), EA-1228 FUND I, A SERIES OF HRZ SELECT TEMPEST, LP (CIK 2006824); containing “minerals”: 1789 MINERALS FUND I, LP (CIK 1791248), AAA MINERALS INC. (CIK 1304741), AB MINERALS INVESTMENT CLUB, LLC (CIK 1562460). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: analyst views on “tempest” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Tevogen bio holdings inc. bullish and bearish analyst opinions

For “Tevogen bio holdings inc. bullish and bearish analyst opinions”, the matching SEC registrant is Tevogen Inc., which trades as TVGN, TVGNW and files under Central Index Key 1860871. EDGAR puts it in the “Biological Products, (No Diagnostic Substances)” industry code with DE as its state or country of incorporation; its earlier registered name was Tevogen Bio Holdings Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-09-30, across 305 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-31 by Tevogen Inc. (CIK 1860871) — source document:

We are a clinical-stage specialty immunotherapy company harnessing one of nature’s most powerful immunological weapons, CD8+ cytotoxic T lymphocytes (“CTLs”), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders, with the aim of addressing the significant unmet needs of large patient populations. We believe that sustainability and commercial success in the forthcoming era of medicine will rely on ensuring patient accessibility through advanced science, innovative business models and engagement throughout various stages of the drug development and commercialization lifecycle. We believe the full potential of T cell therapies remains largely untapped, and aspire to be the first biotechnology company offering commercially attractive, economically viable, and cost-effective personalized T cell therapies.

Financial trend for Tevogen Inc. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from $4.41 million (2022-12-31) to -$26.28 million (2025-12-31), a change of -696.0%; total assets went from $357.14 million (2022-12-31) to $4.38 million (2025-12-31), a change of -98.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1860871, tags Assets, NetIncomeLoss; 4 periods shown, dashes mark figures Tevogen Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Tevogen Inc. (CIK 1860871) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2024-04-26, and the most recent 10-K annual report was filed 2026-03-31. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 48 8-K or 6-K reports in Tevogen Inc.’s recent EDGAR index, the 4 listed here run from 2026-08-26 to 2026-09-30, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1860871 is on the EDGAR company page; the latest 10-K/A there is dated 2026-04-30 and the oldest filing in the recent index dates from 2021-06-10. Insider trades for Tevogen Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

The beachbody company, inc. bullish and bearish analyst opinions

For “The beachbody company, inc. bullish and bearish analyst opinions”, the matching SEC registrant is Beachbody Company, Inc., which trades as BODI, BODYW and files under Central Index Key 1826889. EDGAR puts it in the “Retail-Nonstore Retailers” industry code with DE as its state or country of incorporation; its earlier registered name was Forest Road Acquisition Corp. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-08-18, across 463 filings on record. This is reference material, not trading advice.

Financial trend for Beachbody Company, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $692.20 million (2022-12-31) to $251.73 million (2025-12-31), a change of -63.6%; net income (loss) went from -$194.19 million (2022-12-31) to -$2.86 million (2025-12-31), a change of +98.5%; total assets went from $443.39 million (2022-12-31) to $147.03 million (2025-12-31), a change of -66.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1826889, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Beachbody Company, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Beachbody Company, Inc. (CIK 1826889) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-10, and the most recent 10-K annual report was filed 2026-03-10. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 79 8-K or 6-K reports in Beachbody Company, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-12 to 2026-08-10, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 463 recent EDGAR filings, Beachbody Company, Inc. most often filed 4 (108), 8-K (79), 424B3 (75), 425 (45). A selection from 2026-08-10 to 2026-08-18:

The full record for CIK 1826889 is on the EDGAR company page; the latest 10-K there is dated 2026-03-10 and the oldest filing in the recent index dates from 2020-10-08. Insider trades for Beachbody Company, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Theriva biologics, inc. bullish and bearish analyst opinions

For “Theriva biologics, inc. bullish and bearish analyst opinions”, the matching SEC registrant is Theriva Biologics, Inc., which trades as TOVX and files under Central Index Key 894158. EDGAR puts it in the “Pharmaceutical Preparations” industry code with NV as its state or country of incorporation; its earlier registered name was Synthetic Biologics, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a DEF 14A filed 2026-10-20, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-12 by Theriva Biologics, Inc. (CIK 894158) — source document:

VCN - 01 has been evaluated in a Phase 2b clinical study for the treatment of pancreatic cancer (“VIRAGE”), and a Phase 1 clinical study for the treatment of retinoblastoma, as well as various other Phase 1 clinical studies for the treatment of other solid tumors including head and neck squamous cell carcinoma. ​ Prior to the Acquisition, our focus was on developing therapeutics designed to treat gastrointestinal (GI) diseases which included our clinical development candidates: (1) SYN-004 (ribaxamase), which is designed to degrade certain commonly used intravenous (IV) beta-lactam antibiotics within the GI tract to prevent microbiome damage, thereby preventing overgrowth and infection by pathogenic organisms such as Clostridioides difficile infection (CDI) and vancomycin resistant Enterococci (VRE), and reducing the incidence and severity of acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant (HCT) recipients, and (2) SYN-020, a recombinant oral formulation of the enzyme intestinal alkaline phosphatase (IAP) produced under current good manufacturing practices (“cGMP”) conditions and intended to treat both local GI and systemic diseases.

Financial trend for Theriva Biologics, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$19.68 million (2022-12-31) to -$18.35 million (2023-12-31), a change of +6.8%; total assets went from $71.86 million (2022-12-31) to $38.24 million (2025-12-31), a change of -46.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 894158, tags Assets, NetIncomeLoss, SalesRevenueNet; 4 periods shown, dashes mark figures Theriva Biologics, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Theriva Biologics, Inc. (CIK 894158) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-11, and the most recent 10-K annual report was filed 2026-03-12. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 350 8-K or 6-K reports in Theriva Biologics, Inc.’s recent EDGAR index, the 4 listed here run from 2026-07-07 to 2026-08-11, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 894158 is on the EDGAR company page; the latest 10-K there is dated 2026-03-12 and the oldest filing in the recent index dates from 1998-06-23. Insider trades for Theriva Biologics, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Tootsie roll industries, inc. bullish and bearish analyst opinions

For “Tootsie roll industries, inc. bullish and bearish analyst opinions”, the matching SEC registrant is TOOTSIE ROLL INDUSTRIES INC, which trades as TR, TROLB and files under Central Index Key 98677. EDGAR puts it in the “Sugar & Confectionery Products” industry code with VA as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-22, across 414 filings on record. This is reference material, not trading advice.

Financial trend for TOOTSIE ROLL INDUSTRIES INC from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $686.97 million (2022-12-31) to $732.52 million (2025-12-31), a change of +6.6%; net income (loss) went from $75.94 million (2022-12-31) to $100.05 million (2025-12-31), a change of +31.8%; total assets went from $1.02 billion (2022-12-31) to $1.25 billion (2025-12-31), a change of +23.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 98677, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures TOOTSIE ROLL INDUSTRIES INC did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on TOOTSIE ROLL INDUSTRIES INC (CIK 98677) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-10-22, and the most recent 10-K annual report was filed 2026-02-27. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 131 8-K or 6-K reports in TOOTSIE ROLL INDUSTRIES INC’s recent EDGAR index, the 4 listed here run from 2026-05-11 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 414 recent EDGAR filings, TOOTSIE ROLL INDUSTRIES INC most often filed 8-K (131), 10-Q (98), 4 (38), DEF 14A (33). A selection from 2026-04-30 to 2026-08-07:

The full record for CIK 98677 is on the EDGAR company page; the latest 10-K there is dated 2026-02-27 and the oldest filing in the recent index dates from 1994-03-22. Insider trades for TOOTSIE ROLL INDUSTRIES INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Toyo tire corporation bullish and bearish analyst opinions

What this search refers to. Toyo Tire Corporation is a Japanese tyre manufacturer listed on the Tokyo Stock Exchange; its annual securities reports are filed on EDINET. Official source: disclosure2.edinet-fsa.go.jp.

No SEC filer could be matched to “Toyo tire corporation bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Toyo tire corporation” appears in 2066+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “toyo” (search terms considered: toyo, tire, corporation).

In the 100 most relevant full-text hits returned for “Toyo tire corporation”, filings range from 2019-11-25 to 2026-08-28. The filers whose documents mention it most often are VICTORY PORTFOLIOS (CIK 0000802716) (34 hits); JNL SERIES TRUST (CIK 0000933691) (15 hits); Segall Bryant & Hamill Trust (CIK 0000357204) (13 hits); NORTHERN FUNDS (CIK 0000916620) (11 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 8 entities whose registered name contains the word “toyo”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “toyo” 8, “tire” 52, “corporation” 486. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “toyo” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Tpcs public company limited bullish and bearish analyst opinions

“Public Company Limited” is the legal form Thai law requires for companies listed on SET or mai. The name “Tpcs public company limited” therefore points to a company organised in Thailand, and its official disclosures are on the Stock Exchange of Thailand (SET) company pages and the SEC Thailand filing system (www.set.or.th), not on EDGAR.

No SEC filer could be matched to “Tpcs public company limited bullish and bearish analyst opinions” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Tpcs public company limited”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “tpcs” (search terms considered: tpcs, public).

Even the shorter phrase “Tpcs public limited” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (tpcs, public) point to a business outside the SEC system or one known by another legal name.

EDGAR’s company index has 0 entities whose registered name contains the word “tpcs”, so the business is most likely not registered with the SEC under that name.

Word by word, the number of EDGAR registrant names containing each term of this search is: “tpcs” 0, “public” 466. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “public”: 30 THREE SIXTY PUBLIC FINANCE, INC. (CIK 1733578), 50T PUBLIC DAE FUND, LP (CIK 2099654), AAA PUBLIC ADJUSTING GROUP INC (CIK 1419697). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: analyst views on “tpcs” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Transcat, inc. bullish and bearish analyst opinions

For “Transcat, inc. bullish and bearish analyst opinions”, the matching SEC registrant is TRANSCAT INC, which trades as TRNS and files under Central Index Key 99302. EDGAR puts it in the “Instruments For Meas & Testing of Electricity & Elec Signals” industry code with OH as its state or country of incorporation; its earlier registered name was TRANSMATION INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-09-10, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-05-27 by TRANSCAT INC (CIK 99302) — source document:

Transcat, Inc. (“Transcat”, the “Company,” “we” or “us”) is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (“CMMS”), and pipette services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices and other FDA-regulated businesses, as well as aerospace and defense and energy and utilities. Transcat also operates as a leading value-added distributor that markets, sells and rents new and used national and proprietary brand instruments. We conduct our business through two operating segments: service (“Service”) and distribution (“Distribution”). See Note 7 to our Consolidated Financial Statements in this report for financial information for these segments.

Financial trend for TRANSCAT INC from annual reports, periods 2023-03-25 to 2026-03-28: revenue went from $230.57 million (2023-03-25) to $331.88 million (2026-03-28), a change of +43.9%; net income (loss) went from $10.69 million (2023-03-25) to $5.38 million (2026-03-28), a change of -49.7%; total assets went from $195.75 million (2023-03-25) to $480.49 million (2026-03-28), a change of +145.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 99302, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures TRANSCAT INC did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on TRANSCAT INC (CIK 99302) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-04, and the most recent 10-K annual report was filed 2026-05-27. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 181 8-K or 6-K reports in TRANSCAT INC’s recent EDGAR index, the 4 listed here run from 2026-05-19 to 2026-09-10, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 99302 is on the EDGAR company page; the latest 10-K there is dated 2026-05-27 and the oldest filing in the recent index dates from 2007-08-20. Insider trades for TRANSCAT INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Trinity league india limited bullish and bearish analyst opinions

Read from its name, “Trinity league india limited” is a India entity — “Private Limited” (Pvt Ltd) is an Indian private company form whose shares cannot be offered to the public. Its accounts and exchange notices are published through the Ministry of Corporate Affairs (MCA) company master data and, for listed firms, BSE/NSE filings (www.mca.gov.in); the SEC only receives filings from such a company if it sells registered securities in the U.S.

No SEC filer could be matched to “Trinity league india limited bullish and bearish analyst opinions” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Trinity league india limited”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “trinity” (search terms considered: trinity, league, india).

Even the shorter phrase “Trinity league india” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (trinity, league, india) point to a business outside the SEC system or one known by another legal name.

The wording suggests a business based in India. Companies there file with NSE/BSE and the Securities and Exchange Board of India (SEBI) rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “trinity” is therefore the India regulator or exchange site, where annual reports and stock-exchange announcements are published.

EDGAR’s company index has 194+ entities whose registered name contains the word “trinity”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “trinity” 395, “league” 98, “india” 472. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “trinity” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

United bankers oyj bullish and bearish analyst opinions

“Oyj” is the Finnish public limited company form (julkinen osakeyhtiö). The name “United bankers oyj” therefore points to a company organised in Finland, and its official disclosures are on Nasdaq Helsinki company announcements and the Finnish Trade Register (PRH) (www.ytj.fi), not on EDGAR.

No SEC filer could be matched to “United bankers oyj bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “United bankers oyj” appears in 139+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “united” (search terms considered: united, bankers).

The wording suggests a business based in Finland. Companies there file with Nasdaq Helsinki and the Finnish FIN-FSA rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “united” is therefore the Finland regulator or exchange site, where annual reports and stock-exchange announcements are published.

In the 100 most relevant full-text hits returned for “United bankers oyj”, filings range from 2024-08-28 to 2026-08-28. The filers whose documents mention it most often are SPDR INDEX SHARES FUNDS (CIK 0001168164) (100 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 191+ entities whose registered name contains the word “united”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “united” 468, “bankers” 110. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “united” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET